HLA-B*51:01 and CYP2C9*3 Are Risk Factors for Phenytoin-Induced Eruption in the Japanese Population: Analysis of Data From the Biobank Japan Project

Comparison of effects of UGT1A1*6 and UGT1A1*28 on irinotecan-induced adverse reactions in the Japanese population: analysis of the Biobank Japan Project

Association of HLA-A*31:01 Screening With the Incidence of Carbamazepine-Induced Cutaneous Adverse Reactions in a Japanese Population

New Pharmacogenomics Research Network: An Open Community Catalyzing Research and Translation in Precision Medicine

Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs

Association of genetic polymorphisms in SLCO1B3 and ABCC2 with docetaxel-induced leukopenia

Single nucleotide polymorphism in ABCG2 is associated with irinotecan-induced severe myelosuppression

Estimation of the warfarin dose with clinical and pharmacogenetic data

Association study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patients

Genome-wide association study identifies genetic determinants of warfarin responsiveness for Japanese

Genome-wide association study of epirubicin-induced leukopenia in Japanese patients

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

A genome-wide association study identifies four genetic markers for hematological toxicities in cancer patients receiving gemcitabine therapy

Genome-wide association study of chemotherapeutic agent-induced severe neutropenia/leucopenia for patients in Biobank Japan

Pathway analysis of genome-wide data improves warfarin dose prediction

A genome-wide association study of chemotherapy-induced alopecia in breast cancer patients

Specific HLA types are associated with antiepileptic drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese subjects